Prior chest imaging can sometimes be just as predictive of adverse events after surgery as updated imaging, according to new data set to be presented at the annual conference of the American College of Cardiology on March 5. 

Dual source CT scanners can eliminate the need for beta blockers to control heart rates during coronary CTA exams.  

While the studies on these systems have proven them to be effective in diagnosing and treating COVID in specific cohorts, the varying settings in which they were used can make it difficult to derive definitive conclusions on their efficacy.

Scans on these patients show a combination of fibrosis, thickening, honeycombing, cystic changes and dilation of the bronchi, among other imaging features.

Using risk model-based strategies to determine who should undergo low-dose CT lung cancer screening is more cost effective than current U.S. Preventive Services Task Force guidelines.

Radiomics features could be especially useful for determining TSS in scenarios where clinical data is lacking or unreliable, such as when patients have altered mental status.

Not only does the low-volume contrast protocol preserve supplies, it also protects patients who might be vulnerable to adverse reactions and/or side effects from contrast use. 

A study published in the January issue of the Journal of Nuclear Medicine reveals that nearly half of Medicare patients with NSCLC in the United States do not complete recommended FDG PET/CT scans prior to treatment.